Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $138.00 at Evercore ISI

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its target price hoisted by investment analysts at Evercore ISI from $108.00 to $138.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has an “in-line” rating on the biotechnology company’s stock. Evercore ISI’s price objective would indicate a potential upside of 2.32% from the […]

Related Keywords

Canada ,Wellington ,New Zealand General ,New Zealand ,Blackrock , ,Morgan Stanley ,Vanguard Group Inc ,Deutsche Bank Aktiengesellschaft ,Blackrock Inc ,Royal Bank ,Sarepta Therapeutics Company Profile ,Sarepta Therapeutics Inc ,Capital International Investors ,Citigroup ,Nasdaq ,Wellington Management Group ,Avoro Capital Advisors ,Sarepta Therapeutics ,Get Free Report ,International Investors ,Capital Advisors ,Management Group ,Sarepta Therapeutics Daily ,